Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, Aran Research & Development (1982)'s highest 3-Year average EPS without NRI Growth Rate was 60.20% per year. The lowest was -60.90% per year. And the median was 12.20% per year.
Aran Research & Development (1982) (XTAE:ARAN) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Aran Research & Development (1982) EPS (Diluted) Related Terms
Aran Research & Development (1982) EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aran Research & Development (1982) EPS (Diluted) Chart
For the Conglomerates subindustry, Aran Research & Development (1982)'s PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aran Research & Development (1982) PE Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Aran Research & Development (1982)'s PE Ratio distribution charts can be found below:
* The bar in red indicates where Aran Research & Development (1982)'s PE Ratio falls into.
Aran Research & Development (1982) EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪4.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aran Research & Development (1982) (XTAE:ARAN) has a EPS (Diluted) of ₪4.09 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Aran Research & Development (1982) and its competitors.
Is Aran Research & Development (1982)'s EPS (Diluted) too high?
Aran Research & Development (1982)'s current EPS (Diluted) is ₪4.09. Overall, Aran Research & Development (1982) has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aran Research & Development (1982)'s EPS (Diluted) compare to MMM and HON?
Aran Research & Development (1982)'s EPS (Diluted) of ₪4.09 can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Conglomerates company?
A good EPS (Diluted) depends on the Conglomerates industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Aran Research & Development (1982) and its competitors. Aran Research & Development (1982)'s current EPS (Diluted) is ₪4.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aran Research & Development (1982) stock overvalued right now?
Based on GuruFocus' analysis, Aran Research & Development (1982) (XTAE:ARAN) is currently considered Fairly Valued. The stock's GF Value™ is ₪37.11, compared to a current price of ₪39.78 — trading 7.2% above its estimated fair value. The current EPS (Diluted) is ₪4.09. Aran Research & Development (1982)'s overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Aran Research & Development (1982) (XTAE:ARAN), the current EPS (Diluted) is ₪4.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aran Research & Development (1982) (XTAE:ARAN) Overvalued in 2026?
Based on GuruFocus' analysis, Aran Research & Development (1982) stock appears to be overvalued.
The current stock price of ₪39.78 is trading 7.2% above its estimated GF Value™ of ₪37.11.
GuruFocus considers Aran Research & Development (1982) to be Fairly Valued.
Key valuation signals for XTAE:ARAN:
EPS (Diluted): ₪4.09
GF Value™: ₪37.11 vs. price of ₪39.78 (7.2% above fair value)
No single metric tells the full story. See the XTAE:ARAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aran Research & Development (1982) Ltd is a product design and development company. It also manufactures equipment for the plastics industry. It develops & supplies products including medical devices, water, defense & HLS, consumer & industrial and injection molds. It also has medical startups which focuses on Cardiovascular, Laparoscopy and Gastrointestinal endoscopy.
78GF Score
Get the complete analysis for XTAE:ARAN
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ARAN has been successfully added to your 
